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A magnetic solid-phase extraction (MSPE) procedure on the
newly synthesized magnetic β-cyclodextrin functionalized
with toluene diisocyanate (TDI) as a linker and further
modified with bio-polymeric spores of sporopollenin (MSp-
TDI-βCD), was developed for the extraction of nonsteroidal
anti-inflammatory drugs (NSAIDs), namely, indoprofen (INP),
ketoprofen (KTP), ibuprofen (IBP) and fenoprofen (FNP)
from water samples prior to their HPLC-DAD determination.
The newly synthesized MSp-TDI-βCD was comprehensibly
characterized using FT-IR, XRD, SEM-EDX, BET and VSM
analyses. The separation of selected NSAIDs on MSp-TDI-
βCD from aqueous solution was simply achieved by applying
an external magnetic field via a permanent magnet. The
MSPE parameters affecting extraction performance, i.e. sorbent
2018 The Authors. Published by the Royal Society under the terms of the Creative Commons
Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted
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dosage, sample volume, extraction and desorption time, type of organic eluent and volume and
solution pH were investigated and optimized. The proposed method showed linear range between
0.5 and 500 ng ml−1, low limit of detection at S/N = 3 (0.16–0.37 ng ml−1) and limit of quantification at
S/N = 10 (0.53–1.22 ng ml−1). The inter-day (n= 15) and intra-day (n= 5) precision for the proposed
methods given by relative standard deviation (RSD%) was in the range of 2.5–4.0 and 2.1–5.5,
respectively. The extraction recoveries of NSAIDs from environmental samples (tap, drinking and
river water) ranged from 92.5% to 123.6%, with satisfactory precision (RSD% less than 12.4%).
1. Introduction
In the past few decades, massive manufacturing of pharmaceutical products has been creating serious
environmental problems because contaminated effluents of pharmaceutical products contain highly
stable and persistent environmental pollutants [1–3]. Numerous non-metabolized drugs which are not
fully absorbed by and are excreted from the human body generally may reach the waste compartment
through effluents [4]. Wastewater from hospitals, pharmaceutical industries and private households,
by virtue of these therapeutic drug agents, leads to the contamination of water sources and poses
a severe threat to human health [1,2]. Undoubtedly, nonsteroidal anti-inflammatory drugs (NSAIDs)
are renowned as one of the most subscribed drugs worldwide and are used to relieve inflammatory,
chronic and acute pain conditions such as osteoarthritis and orthopaedic fracture. In addition, NSAIDs
also possess an antipyretic as well as analgesic property that has been used in human and veterinary
medication. But, due to poor degradation factor and high water solubility, prolonged consumption of
these drugs leads to extensive water contamination. Moreover, according to the international Council
Directive 96/23/EC report, among the pharmaceutical products, NSAIDs have been recognized as
perilous residues [4]. Consequently, taking into consideration the detrimental effects, the US Food
and Drug Administration (FDA) established a maximum allowed concentration of pharmaceutical
compound of 1.0 ng ml−1 into aquatic environment [3]. Therefore, by virtue of well-known toxicity
and detrimental effect, the precise determination and detoxification of NSAIDs contaminated aqueous
environment is of significant importance [4,5]. Literature survey indicated that determination of NSAIDs
in waste water samples, involving pre-concentration step and separation followed by quantification, is
necessary due to its low concentration in complex matrix [6,7]. More than that, the selectivity issues also
play an important role in the determination of NSAIDs in water samples [8].
Several techniques, including liquid–liquid extraction (LLE) [9], liquid-phase microextraction
(LPME) [10], solid-phase microextraction (SPME) [11] and solid-phase extraction (SPE) [12], have been
applied to remediate the NSAIDs and their degraded products from the aqueous environment. Majority
of these techniques are tedious and time-consuming with consequent risks such as use of toxic solvents
in LLE and use of expensive cartridges in SPE [13–15]. SPME also encounters limitation related to low
extraction efficiencies and low reproducibility and robustness because of fragile fibres as well as use
of expendable solid-phase cartridges which have limited lifetime [16,17]. Comparatively, magnetic solid-
phase extraction (MSPE), due to its simplicity, significant recovery, short extraction time, high enrichment
factor and low cost, is renowned as an advantageous and authentic method [18]. Abundant literature
reported that MSPE has been comprehensibly used to intoxicate the phenol [19], PAHs [20] and [21]
contaminated effluents of pesticides [22–24]. As MSPE is based on magnetic sorbent, the exploitation
of innovative highly selective NSAID sorbents, which can be easily regenerated and effectively used in
aqueous media, has currently become a focus of intensive research [6,25]. Fe3O4 magnetic nanoparticles
(MNPs), due to large surface area, extraordinary paramagnetic properties, stability, less toxicity, ease
of synthesis as well as versatile functionalization, deserve particular attention [6,26]. Renowned bio-
polymeric material, i.e. sporopollenin, is recognized as a potential SPE biosorbent by virtue of its
remarkable physical, chemical/biological stability and chemical reactivity. Additionally, the exines are
hollow, 2 mm thick walls perforated with numerous channels which make them porous so that both the
outer and inner surfaces are potentially available for binding/magnetization [27].
On the other hand, the second generation of synthetic supramolecules, i.e. cyclodextrins (CDs), has
received considerable importance in the field of host–guest chemistry due to its tendency to bind the
variety of pollutants with unique size-selectivity [22,28,29]. CDs are torus-shaped cyclic oligosaccharides
with an internal hydrophobic cavity containing 6–12 glucose units joined together by α-1,4-glycosidic
linkages [30]. In the last three decades, CD-based materials have been significantly developed owing to
CDs’ unique character which can form noncovalent inclusion complex with other compounds through
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indoprofen (pKa = 4.4)a ketoprofen (pKa = 4.2)a
fenoprofen (pKa = 4.5)bibuprofen (pKa = 4.51)a
Figure 1. The chemical structures of the selected NSAIDs and pKa value. aDe Oliveira et al. [11]. bSee http://www.drugbank.ca (accessed
on 6 July 2017).
host–guest interactions by encapsulating either completely or partially fit into the lipophilic cavity [31].
The cavity of CDs provides a hydrophobic space in which a guest can be sequestered in an aqueous
medium. CDs are known to form stable complexes with a wide range of compounds, including dyes,
organic compounds and metal ions [32]. To the best of our knowledge, there is no example of βCD
functionalized toluene diisocyanate (TDI)-modified bio-polymeric spores of sporopollenin (MSp-TDI-
βCD)-based MSPE sorbent for the extraction of NSAIDs [26]. Consequently, in the current study
we intend to develop a green MSPE sorbent by using bio-polymer material and supramolecular
host molecule, βCD which is grafted onto sporopollenin. The βCD-functionalized TDI-modified bio-
polymeric spores were magnetized with iron oxide nanoparticles (MSp-TDI-βCD). The synthesized
MSp-TDI-βCD was successfully employed as an MSPE sorbent for the extraction of selected NSAIDs
(figure 1) from water samples prior to their HPLC-DAD determination.
2. Material and methods
2.1. Materials
‘Lycopodium clavatum’ sporopollenin with a particle size of 25 µm was purchased from Aldrich
(Steinheim, Germany). All chemicals used were of analytical grade and purchased from Merck
(Darmstadt, Germany) or Sigma (Steinheim, Germany) and used without further purification. All
commercial grade solvents stored over molecular sieves (4 Å, 8–12 mesh) from (Steinheim, Germany).
The pH of the solution was adjusted by mixing appropriate amount of HCl and/or NaOH (0.1 M).
Deionized water that had been passed through a Milli-Q system (Lane End, UK) was used for the
preparation of solutions.
2.2. Instruments
The FT-IR spectrum was obtained using ATR mode on a Spectrum 400 Perkin Elmer in the range of 4000–
450 cm−1 with diamond as a detector. The SEM-EDX analysis was performed using HITACHI SU8220
scanning electronic microscopy from OXFORD Instrument (Oxfordshire, UK). The magnetization of
functionalized MNP was measured using vibrating sample magnetometer (VSM LakeShore 7400
series). X-ray diffraction (XRD) patterns of the samples were taken using PANalytical Empyrean
X-ray diffractometer (EA Almelo, The Netherlands) from 2Θ = 15° to 75° at room temperature using
Cu Kα radiation at a wavelength of 1.5418 Å at a scan rate of 0.02 s−1. The surface area and porosity
were measured using Brunauer–Emmett–Teller (BET) by nitrogen adsorption–desorption isotherm in
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Micromeritics Tristar II ASAP 2020, (GA, USA). HPLC system (Kyoto, Japan), consisting of LC-20AT
pump, SPD-M20A diode array detector, SIL-20A HT autosampler and CTO-10AS VP column oven, was
used for NSAID determination. The system was equipped with a Hypersil gold C-18 reverse phase
column (250 × 4.6 mm), particle size (5 µm) from ThermoScience (MA, USA).
2.3. HPLC parameters and conditions
HPLC-DAD system was used for the chromatographic identification of the selected NSAIDs from the
water samples. The chromatographic separation was carried out using acidified (1% with acetic acid)
water/acetonitrile (50 : 50 v/v) as a mobile phase at a flow rate of 1 ml min−1 for selected NSAIDs. The
HPLC column temperature was set at 40°C. The sample inject volume was 10 µl. The DAD detection for
the selected NSAIDs was carried out at multiple wavelengths, i.e. 281, 255, 271 and 219 nm for indoprofen
(INP), ketoprofen (KTP), ibuprofen (IBP) and fenoprofen (FNP) respectively.
2.4. Synthesis
2.4.1. Functionalization of sporopollenin with TDI (Sp-TDI)
Two grams of sporopollenin and 10 ml of TDI were mixed using a magnetic stirrer in 20 ml dry toluene.
The reaction mixture was stirred for 4 h at room temperature under inert atmosphere. Then, the resultant
Sp-TDI was separated by centrifugation at 1792 RCF for 5 min and sequentially washed with excess of
dry toluene. The sample was dried and stored in a desiccator.
2.4.2. Preparation ofβCD-based TDI-modified sporopollenin (Sp-TDI-βCD)
In 20 ml of dry N,N-dimethylformamide (DMF), 0.7 g of βCD was dissolved, following the addition of
1.5 g of freshly prepared Sp-TDI; the reaction mixture was stirred under nitrogen atmosphere at 70°C
for 2 h. Then the resultant Sp-TDI-βCD was washed with excess of acetone and deionized water for the
removal of unreacted particles and dried under vacuum at 60°C.
2.4.3. Preparation of magneticβCD-based sporopollenin (MSp-TDI-βCD)
The magnetization of βCD-functionalized TDI-modified sporopollenin (Sp-TDI-βCD) was carried out as
follows: 13.32 g of FeCl3.6H2O, 19.88 g of FeCl2.4H2O, 5 ml of HCl (5 M), 40 ml of deionized water and
5 ml of ethanol were mixed in a flask followed by heating to 40°C until complete dissolution of the salts.
Then 1.0 g of the freshly prepared Sp-TDI-βCD was redispersed in 30 ml of the solution and stirred for
2 h at room temperature. The Sp-TDI-βCD suspension was filtered and the filtrate was quickly washed
with deionized water and immediately transferred to a 0.1 M ammonia solution. After 2 h stirring at
room temperature, the ‘magnetic βCD-functionalized TDI-modified sporopollenin’ (MSp-TDI-βCD) was
separated from the solution using an external magnet and washed thoroughly with deionized water and
dried under vacuum. Figure 2 illustrates the synthesis pathway of MSp-TDI-βCD sorbent.
2.5. Magnetic solid-phase extraction
For MSPE of NSAIDs, 10 mg MSp-TDI-βCD sorbent was added to 200 ml of deionized water spiked with
the mixture of INP, KTP, IBP and FNP with pH 4. The mixture was stirred vigorously for 30 min to make
the sorbent disperse uniformly in the solution. Then, the sorbent was isolated from the solution by using
an external magnet. The solution became limpid and the upper solution was decanted after 5 min. Then,
1.5 ml of acetonitrile was added to elute the NSAIDs adsorbed on MSp-TDI-βCD and was horizontally
shaken for 30 min. The collected eluate was dried using stream nitrogen gas and re-dissolved in 0.7 ml
of acetonitrile. Finally, 10 µl portion of the eluate was injected into HPLC for analysis. Furthermore,
enrichment factor can be calculated which is the ratio of highest sample volume over lowest sample
volume [33–35]. In the current study, the highest volume and the lowest sample volume were 200 ml and
0.7 ml, respectively.
2.6. Real sample preparation
Three environmental water samples, namely tap, drinking and river water were used to assess the field
application of the synthesized MSp-TDI-βCD towards the extraction of the selected NSAIDs. Tap water
sample was obtained from the analytical chemistry laboratory of University of Malaya, Malaysia, while
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Figure 2. Schematic routes for the synthesis of MSp-TDI-βCD sorbent.
river and drinking water samples were collected from Sungai Sendat, Selangor, Malaysia. The collected
samples were stored at 4°C prior to use.
3. Results and discussion
3.1. Synthesis
The aim of this study was to design a new bio-polymer hybrid sporopollenin-based magnetic material
with supramolecular βCD host and investigate its extraction properties towards the selected NSAIDs. In
the first step, sporopollenin surface was connected with TDI as a linker by connecting at para position
of isocyanate group. In the second step, the sporopollenin surface attached with TDI was functionalized
with βCD after inter-connecting at ortho position of isocyanate in the presence of dry DMF. In the final
step, in order to adopt magnetic behaviour sorbent, magnetization of sporopollenin surface was achieved
by the embedded MNPs inside the pores of Sp-TDI-βCD surface by adding Fe2+ and Fe3+ ions in the
presence of basic condition. Finally, the resultant bio-polymer hybrid MSp-TDI-βCD sorbent was chosen
as the precursor.
3.2. Characterization of sorbent
Functionalization of sporopollenin with TDI (synthesis of Sp-TDI), modification of βCD with TDI
functionalized sporopollenin (synthesis of Sp-TDI-βCD) and magnetization of Sp-TDI-βCD (synthesis
of MSp-TDI-βCD) were comprehensibly confirmed by using FT-IR, SEM-EDX spectroscopy as well as
XRD, BET and VSM analysis.
Sporopollenin following the functionalization process with TDI shows some additional bands at
around 2276, 1709, 1603 and 1230 cm−1 for N=C=O, C=O and C–N groups (figure 3b). The appearance
of isocyanate and carbonyl bands at 2276, 1709 and 1603 cm−1 clearly indicates the incorporation of
isocyanate functionalities on the surface of sporopollenin. Additional peak at 1230 cm−1 (figure 3b) for
C–N groups stretching also confirmed the successful functionalization. On the other hand, disappearance
of characteristic peaks of isocyanate group (N=C=O) vibration shown in figure 3c at 2276 cm−1 due to
the reaction between isocyano group with βCD is qualitative evidence for the formation of Sp-TDI-
βCD. Hence, it indicates that βCD is successfully bonded onto the surface of the Sp-TDI. Moreover,
6rsos.royalsocietypublishing.org
R.Soc.opensci.5:171311
................................................
562
2276 1709 1603
1230
4000 3000 2000 1000 0
wavenumber (cm–1)
%
T (b)
(a)
(c)
(d )
Figure 3. FTIR spectra of (a) sporopollenin, (b) Sp-TDI, (c) Sp-TDI-βCD and (d) MSp-TDI-βCD.
(a) (c)(b)
Figure 4. SEM images of (a) sporopollenin, (b) Sp-TDI-βCD and (c) MSp-TDI-βCD.
all significant peaks of βCD in the range of 900–1709 cm−1 were present with a small shift. Both
TDI-grafted sporopollenin (Sp-TDI) and βCD-modified sporopollenin (Sp-TDI-βCD) have very similar
absorption patterns, but the FT-IR spectral analysis shows clearly different bands at around 562 cm−1.
The magnetization of Sp-TDI-βCD with Fe3O4 MNPs and formation of MSp-TDI-βCD can be confirmed
by the appearance of Fe-O stretching at around 562 cm−1 (figure 3d).
The morphological and structural analysis of the synthesized Sp-TDI-βCD and MSp-TDI-βCD
were studied through scanning electron microscope (SEM). From the SEM micrograph of the raw
sporopollenin (figure 4a), a smooth morphology of the sporopollenin network with open and uniform
interconnected pore structure can be seen. While the SEM image of Sp-TDI-βCD (figure 4b) showed
that following the modification process with βCD the pores of sporopollenin changed to be rough
and bumpy filled with βCD molecules. SEM micrograph of the MSp-TDI-βCD (figure 4c) reveals
that the magnetite nanoparticles are predominantly localized inside the open pores of sporopollenin.
Hence, these images reveal that the magnetic nanoparticles have been embedded inside the pores
of sporopollenin. Moreover, to confirm the formation of Sp-TDI-βCD and MSp-TDI-βCD and to
investigate the elemental composition as well as distribution of magnetic particles in the newly prepared
sorbents, energy-dispersive X-ray spectroscopy (EDX) was performed using the SEM-EDX analysis.
The obtained EDX spectrum of Sp-TDI-βCD along with SEM image (figure 5a) obviously reveals
the formation of Sp-TDI-βCD. Raw sporopollenin only contains hydrogen, carbon and oxygen [36].
EDX results (figure 5a) showed that 23.21% of nitrogen originated from isocyanate group after
functionalization of sporopollenin with TDI molecule. Meanwhile, after magnetization process with
Fe3O4 EDX spectrum of MSp-TDI-βCD (figure 5b) showed the presence of 18.82% of iron. The presence
of iron magnetite indicates that the final material MSp-TDI-βCD was successfully filled with magnetic
nanoparticle Fe3O4.
The XRD analyses were performed to measure the crystallinity of Sp-TDI, Sp-TDI-βCD and MSp-
TDI-βCD. Sp-TDI exhibits broad diffraction peaks at approximately 25° which is typically observed for
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Figure 5. EDX spectra of (a) Sp-TDI-βCD and (b) MSp-TDI-βCD.
Table 1. Physical properties of Sporopollenin, Sp-TDI-βCD and MSp-TDI-βCD.
sample surface area (m2 g−1) pore volume (cm3 g−1) pore size (nm)
sporopollenin 2.2675 0.0014 2.5990
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Sp-TDI-βCD 2.7263 0.0017 2.5091
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
MSp-TDI-βCD 16.5086 0.09223 22.348
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
amorphous material (electronic supplementary material, figure S1). Meanwhile, few diffraction peaks
appear at approximately 10°–20° when βCD was incorporated on the surface of Sp-TDI as βCD existed
as crystalline form. Hence, it indicates that βCD improves the crystallinity of Sp-TDI-βCD (electronic
supplementary material, figure S1b). According to Joint Committee on Powder Diffraction Standards
(JCPDS) reference pattern of magnetite (00-019-0629), six diffraction peaks of Fe3O4 are observed in MSp-
TDI-βCD in electronic supplementary material, figure S1c, which are (220), (311), (400), (422), (511), and
(440) related to cubic spine plane of Fe3O4 and confirming the presence of Fe3O4. It is also observed that
no distinct diffraction peaks of βCD appear for MSp-TDI-βCD, which indicates that the βCD molecules
are distributed homogeneously without forming any phase-separated crystal aggregates [31,37].
The magnetism behaviour of MSp-TDI-βCD was characterized by the vibrating sample
magnetometer (VSM) technique. MSp-TDI-βCD sample displayed typical superparamagnetic behaviour
(electronic supplementary material, figure S2). The saturation magnetization of analysed sample was
31.49 emu g−1 and sufficient for magnetic separation as minimal magnetic separation reported was 16.30
emu g−1 [38]. The inset photos in electronic supplementary material, figure S2 showed the sorbent
separation by using external magnetic field.
BET surface area measurements were also made on the MSp-TDI-βCD. Electronic supplementary
material, figure S3 shows N2 adsorption–desorption which is close to type IV of the IUPAC
classification with an evident hysteresis loop in the 0.05–1.0 range, suggesting that the sample is
basically mesoporous [39]. The relatively high specific surface area of the sample calculated by BET is
16.5083 m2 g−1 and is related to the nanometric size of its particles. The surface area can be used to
estimate the pore size according to the equation 4V/SBET, where V is adsorption total pore volume
and SBET is the specific surface area of the MSp-TDI-βCD. The pore size calculated from the surface
area is approximately 22.3480 nm. Table 1 shows the pore size, pore volume and SBET for sporopollenin,
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Figure 6. The effect of (a) adsorbent dosage, and (b) sample volume for the extraction of NSAIDs usingMSp-TDI-βCD and analysis using
HPLC-DAD. HPLC conditions: acidified (1%with acetic acid) water/acetonitrile (50 : 50 v/v) as amobile phase at a flow rate of 1 ml min−1,
the HPLC column temperature was set at 40°C, the sample injection volume was 10µl, the DAD detection for the selected NSAIDs was
carried out at multiple wavelengths, i.e. 281, 255, 271 and 219 nm for INP, KTP, IBP and FNP, respectively.
Sp-TDI-βCD and MSp-TDI-βCD. The escalation in the pore size can be caused by dispersity of particles
that make surface area increased as well as increased pore volume. Thus, it will enhance the adsorption
capacity especially for large adsorbate molecule [40].
3.3. Application of magnetic solid-phase extraction
In this study, INP, KTP, IBP and FNP were selected as target NSAID’s drugs analyte in order to
evaluate the MSPE extraction efficiency of the newly prepared MSp-TDI-βCD. The optimal condition
was examined by evaluating various parameters including sorbent dosage, extraction time, sample
volume, type of organic eluent, volume of organic eluent, desorption time and sample solution pH.
3.3.1. Adsorbent dosage
The effect of sorbent dosage on the per cent extraction of NSAIDs was assessed by changing the mass
of sorbent (MSp-TDI-βCD) in the range of 5–50 mg (figure 6a). By increasing the amount of sorbent,
peak area was increased significantly due to the accessible sites. However, the peak area was slightly
decreased with further increasing of sorbent. This could be explained by weak elution efficiency of target
analytes at specific sample volume and extraction/desorption time [41,42]. In addition, sorbent dosage
has a different effect on the different target analytes due to the interaction between adsorption sites and
the nature of NSAIDs. The quantitative extraction of four selected NSAIDs was obtained using 10 mg of
the sorbent and it was sufficient to extract analytes from aqueous samples, thus selected for subsequent
experiment.
3.3.2. Sample volume
High enrichment factor can be obtained by using a large sample volume. Thus, the volume of water
samples ranging from 20 to 250 ml was evaluated. From figure 6b, it can be ensured that highest peak area
was obtained with 200 ml sample volume. However, beyond the 200 ml sample volume, the peak area
decreased significantly probably due to the excessive breakthrough volume [12]. Therefore, the 200 ml
sample volume was selected as the optimum volume for trace sample analysis of selected NSAIDs from
water samples.
3.3.3. Extraction and desorption time
The extraction and desorption time profiles were performed between 5 and 60 min (figure 7a,b). The
maximum peak area was attained at 30 min for all selected NSAIDs and it remained almost at constant
thereon. It can be concluded that extraction and desorption equilibrium between the aqueous phase and
the sorbent was nearly reached after 30 min for both cases. Thus, 30 min extraction and desorption time
were sufficient for the subsequent experiments.
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Figure 8. The effect of (a) type of organic eluent, and (b) volume of organic eluent for the extraction of NSAIDs using MSp-TDI-
βCD and analysis using HPLC-DAD. HPLC conditions: acidified (1% with acetic acid) water/acetonitrile (50 : 50 v/v) as a mobile phase
at a flow rate of 1 ml min−1, the HPLC column temperature was set at 40°C, the sample injection volume was 10µl, the DAD
detection for the selected NSAIDs was carried out at multiple wavelengths, i.e. 281, 255, 271 and 219 nm for INP, KTP, IBP and FNP,
respectively.
3.3.4. Type of organic eluent and volume
Seven types of organic solvents, namely, methanol, acetonitrile, n-hexane, toluene, chloroform, ethyl
acetate and N,N-dimethyl fluoride were used as desorption solvents to examine their effects on the
extraction efficiencies of the selected NSAIDs. As shown in figure 8a, acetonitrile showed the best
extraction of the selected NSAIDs with maximum peak area compared to other organic solvents. This
phenomenon can be explained by the molecular interaction between analyte and sorbent surface. The
predicted intermolecular forces that exist are hydrogen bonding, dipole–dipole interaction and also van
der Waals forces. The role of organic eluent is to disrupt the retentive intermolecular forces between
sorbent surface and analyte. Based on the result, it is expected that methanol gives strong eluent on polar
polymeric sorbent, but for instance acetonitrile gives excellent eluent effect on sorbent surface compared
with methanol. This is because methanol has strong polar eluent strength and it is incapable of disrupting
non-polar interaction site. Acetonitrile is mid to polar–apolar eluent strength that can disrupt the binding
mechanism at polar and non-polar site sorbent surface. n-hexane showed the poor performance eluent
capability due to its non-polar characteristic which is incapable of disrupting the polar site in the presence
of water adsorbent/absorbent on sorbent surface. The effect of the volume of the organic eluent was also
determined. The volume ranging 0.5–3.0 ml of acetonitrile was optimized as shown in figure 8b. The
maximum peak area was obtained with 1.5 ml of acetonitrile. Finally, 1.5 ml of acetonitrile was used in
further experiment.
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Figure 9. The effect of solution pH for the extraction of NSAIDs using MSp-TDI-βCD and analysis using HPLC-DAD. HPLC conditions:
acidified (1%with acetic acid)water/acetonitrile (50 : 50 v/v) as amobile phase at aflow rate of 1 ml min−1, theHPLC column temperature
was set at 40°C, the sample injection volume was 10µl, the DAD detection for the selected NSAIDs was carried out at multiple
wavelengths, i.e. 281, 255, 271 and 219 nm for INP, KTP, IBP and FNP, respectively.
3.3.5. Solution pH
Among the different MSPE affecting parameters, the most important factor influencing the MSPE
efficiency of a sorbent in wastewater treatment is the pH of the solution. The effectiveness of adsorption
is highly dependent on the pH of the medium, as diversity in pH prompts variations in the surface
properties of the sorbent and in the degree of ionization of the selected NSAID molecules. Consequently,
the effect of solution pH on the extraction of selected NSAIDs was investigated using MSp-TDI-βCD
as a sorbent at a pH range from 2 to 10. Results indicated that acidic medium is more suitable for the
extraction of the selected NSAIDs and maximum efficiency for all the selected NSAIDs was obtained at
pH 4. Beyond pH 4, peak area decreased dramatically. The highest peak area for the selected NSAIDs
can be explained on the basis of pKa values. The studied NSAID has pKa value in the range of 4.0–
4.5. As shown in electronic supplementary material, figure S4, the pH zero-point charge (pHzpc) for
sorbent was determined at 6.0. At pH < pKa value, the four NSAIDs mostly existed in deprotonated
forms. The sorbent surface exists in protonated form, which resulted in electrostatic attraction between
analytes and sorbent surface. Hence, higher extraction efficiency was obtained. At pH > 6, the extraction
efficiency was low for targeted analytes due to electrostatic repulsion between NSAIDs and the sorbent
surface. The NSAID molecule was transformed to anionic form, while the sorbent surface also changed
to deprotonated surface. The extraction is affected in a negative way in which strong repulsive force
occurred between the negative sorbent surface and anionic targeted analytes. Hence, the extraction is
higher in acidic environment; pH 4.0 showed the maximum peak area, thus the value was selected for
subsequent experiment (figure 9).
3.3.6. Reusability of the sorbent
The stability and reusability of the sorbent are considered to be crucial factors for practical application
and need to be systematically examined. Hence, reusability investigations of MSp-TDI-βCD were
conducted to examine the effect of synthesized sorbent extraction efficiency after repeated usage cycles.
After each cycle, the sorbent was washed with acetonitrile before the next MSPE application. The
extraction efficiency remained stable after 5 recycles, which indicated that the MSp-TDI-βCD magnetic
particles were mechanically stable and possessed good reusability.
3.4. Method validation
The MSp-TDI-βCD MSPE method was validated at optimized conditions: 10 mg sorbent dosage,
200 ml sample volume, 30 min extraction time, 30 min desorption time, 1.5 ml acetonitrile as organic
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Table 2. Qualitative data of the proposed MSPE method.
precision
analyte linearity (ng ml−1) R2 LOD (ng ml−1) LOQ (ng ml−1) intra (RSD% n= 5) inter (RSD% n= 15)
INP 0.5–500 0.9944 0.16 0.53 4.7 2.7
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
KTP 0.5–500 0.9983 0.18 0.59 5.5 4.0
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IBP 0.5–500 0.9927 0.37 1.22 2.1 2.5
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
FNP 0.5–500 0.9901 0.17 0.58 5.5 3.3
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3. Percentage relative recovery and RSD (n= 5) for spiked NSAIDs from different water samples usingMSp-TDI-βCD for theMSPE
method.
tap water (n= 5) drinking water (n= 5) river water (n= 5)
analyte spiked level (ng ml−1) recovery (%) RSD (%) recovery (%) RSD (%) recovery (%) RSD (%)
INP 10 123.6 9.5 92.9 4.1 112.8 4.2
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100 106.3 3.7 117.7 4.9 121.8 3.3
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
KTP 10 115.6 8.6 92.5 9.6 123.5 5.6
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100 112.8 4.0 103.5 8.4 97.3 3.4
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
IBP 10 109.4 8.2 113.7 12.3 103.4 9.4
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100 112.4 5.3 120.8 8.4 121.9 2.1
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
FNP 10 99.7 9.7 99.6 9.7 108.3 12.4
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
100 118.5 2.9 110.3 1.9 98.9 7.7
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
eluent and sample solution pH 4. Under these optimal conditions, linearity, limit of detection
(LOD), limit of quantification (LOQ) and precision (intra-day and inter-day) were evaluated to
validate the developed method. As shown in table 2, all tested NSAIDs showed good linearity
with good coefficiency of determination (R2 ≥ 0.990). The LOD was calculated based on signal-
to-noise ratio (3 SD/m) (n= 10) and the values obtained were in the range 0.16–0.37 ng ml−1.
The LOQ (10 × SD/m) (n= 10) was also calculated and the values obtained were in the range
0.53–1.22 ng ml−1. Precision was studied in terms of repeatability (intra-day) (n= 5) and reproducibility
(inter-day) (n= 15) expressed as relative standard deviation (RSD). The inter-day precision was
demonstrated by performing five replicates of standard solutions on a single day. The inter-day precision
of the MSPE procedure was performed by performing standard solutions of the same concentration
levels in five replicates on each of the three consecutive days. The linearity, LOD, LOQ and RSD%
precision values are summarized in table 2.
3.5. Environmental water sample analysis
The performance of the developed MSp-TDI-βCD MSPE method for the extraction of selected NSAIDs
was evaluated at optimum conditions for laboratory tap water, drinking water and river water samples to
assess matrix effect on the three latter samples. For the field application, the real sample was spiked with
100 ng ml−1 and 10 ng ml−1 of NSAIDs. Based on the summarized results in table 3, the MSPE method
gives better recovery of NSAIDs in tap water ranging 99.7–123.6% with RSDs (n= 5) in the range of 2.9–
9.7%. For drinking water, the good recovery achieved ranging from 92.5% to 120.8% with RSDs (n= 5)
from 1.9% to 12.3%. Meanwhile, the MSPE method also was tested in river water for the determination of
NSAIDs and gives excellent recovery for spiked NSAIDs in the range of 97.3–123.5% with RSDs (n= 5)
from 2.1% to 12.4%. Figure 10 shows the chromatogram of non-spiked and spiked 10 ng ml−1 of NSAIDs
in three types of real samples.
3.6. Comparative study
Comparative analysis for the extraction of NSAIDs in terms of LOD, recovery and precision with current
work is listed in table 4. The better results for LOD and recovery in comparison with reported sorbents
showed that the newly fabricated MSp-TDI-βCD is more capable of extracting selected NSAIDs.
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Figure 10. Chromatograms of NSAIDs (spiked at 10 ng ml−1 of each NSAIDs) using the proposed MSp-TDI-βCD MSPE method using
spiked tap water sample (a)(i); non-spiked tap water sample (a)(ii); spiked drinking water sample (b)(i); non-spiked drinking water
sample(b)(ii); spiked riverwater sample (c)(i); non-spiked riverwater sample (c)(ii). Peak identification; (1) INP (2) KTP (3) IBP and (4) FNP.
Table 4. Comparison of recovery and LOD of current work to other reported analytical technique and sample matrices.
matrix type of sorbent technique
recovery
(%) RSD (%)
LODs
(ng ml−1) ref.
seawater molecularly imprinted
polymers (MIPs)
MSPE/HPLC 86.3–103.5 2.12–4.33 4.5 [43]
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
water magnetic graphene
@polydopamine
@Zr-MOF
MSPE/HPLC 64.8–92.8 0.62–4.89 0.1–1.0 [44]
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
human plasma 1-butyl-3-
methylimidazolium
bromide-INPs
MSPE/HPLC 98.7–100 0.4–0.8 1.5–5.8 [45]
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
aqueous sample magnetic C18 microsphere MSPE/GC 35.0–99.0 <10.0 0.8–36.0 [46]
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
milk sample magnetic nanoparticles-
graphene-cyanopropyl-
triethoxysilane
(Fe3O4@G-CNPrTEOS)
MSPE/GC 82.0–104.0 4.1–9.1 0.1 [47]
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
tap, drinking and
river water
MSp-TDI-βCD MSPE/HPLC 92.5–123.6 1.9–12.4 0.1–0.4 current study
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4. Conclusion
In this study, βCD-functionalized TDI-modified sporopollenin-based magnetic sorbent (MSp-TDI-βCD)
was successfully synthesized and used as a new sorbent in MSPE for the simple, fast and efficient
extraction of four selected NSAIDs from environmental water samples. Acquired results proved that the
newly proposed MSPE method based on MSp-TDI-βCD was a rapid, reliable and highly efficient method
for the extraction of NSAIDs namely INP, KTP, IBP and FNP from water sample with low LOD and
RSD values with good per cent recoveries when compared with many reported materials. However, this
developed method has limitation for quantification of IBP in aquatic environment due to the obtained
LOQ value of IBP beyond the threshold limit. The field studies also supported the effectiveness of this
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new magnetic MSp-TDI-βCD sorbent which could be useful and has good potential for the extraction of
selected NSAIDs from real water samples.
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